{"quote": {"result": [{"language": "en-US", "region": "US", "quoteType": "EQUITY", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "earningsTimestamp": 1683549000, "earningsTimestampStart": 1691411400, "earningsTimestampEnd": 1691757000, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "epsTrailingTwelveMonths": -2.49, "epsForward": -2.07, "epsCurrentYear": -2.65, "priceEpsCurrentYear": -2.5056603, "sharesOutstanding": 36553000, "bookValue": 3.658, "fiftyDayAverage": 6.446, "fiftyDayAverageChange": 0.19399977, "fiftyDayAverageChangePercent": 0.030096147, "twoHundredDayAverage": 6.531875, "twoHundredDayAverageChange": 0.10812473, "twoHundredDayAverageChangePercent": 0.016553398, "marketCap": 305646496, "forwardPE": -3.2077296, "priceToBook": 1.8151995, "currency": "USD", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "marketState": "PRE", "regularMarketChangePercent": -1.3372979, "regularMarketPrice": 6.64, "firstTradeDateMilliseconds": 1601040600000, "priceHint": 2, "exchange": "NMS", "shortName": "Prelude Therapeutics Incorporat", "longName": "Prelude Therapeutics Incorporated", "messageBoardId": "finmb_373775974", "regularMarketChange": -0.09000015, "regularMarketTime": 1684180805, "regularMarketDayHigh": 6.8, "regularMarketDayRange": "6.58 - 6.8", "regularMarketDayLow": 6.58, "regularMarketVolume": 24447, "regularMarketPreviousClose": 6.73, "bid": 2.92, "ask": 10.62, "bidSize": 9, "askSize": 14, "fullExchangeName": "NasdaqGS", "financialCurrency": "USD", "regularMarketOpen": 6.8, "averageDailyVolume3Month": 77983, "averageDailyVolume10Day": 39770, "fiftyTwoWeekLowChange": 2.475, "fiftyTwoWeekLowChangePercent": 0.5942377, "fiftyTwoWeekRange": "4.165 - 8.9", "fiftyTwoWeekHighChange": -2.2599998, "fiftyTwoWeekHighChangePercent": -0.25393257, "fiftyTwoWeekLow": 4.165, "fiftyTwoWeekHigh": 8.9, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "ipoExpectedDate": "2020-09-25", "averageAnalystRating": "2.6 - Hold", "tradeable": false, "cryptoTradeable": false, "symbol": "PRLD"}], "error": null}, "summary": {"result": [{"assetProfile": {"address1": "200 Powder Mill Road", "city": "Wilmington", "state": "DE", "zip": "19803", "country": "United States", "phone": "(302) 467-1280", "website": "https://preludetx.com", "industry": "Biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "longBusinessSummary": "Prelude Therapeutics Incorporated, a clinical-stage biopharmaceutical company, focuses on the discovery and development of novel precision cancer medicines to underserved patients. It is developing PRT811, which is in Phase 1 clinical trials in solid tumors, including glioblastoma. The company is also developing PRT1419, a myeloid cell leukemia-1 inhibitor, which is in Phase 1 clinical trial for the treatment of selected relapsed/refractory myeloid or B-cell malignancies; PRT2527, a cyclin-dependent kinase 4/6 inhibitor, which is in Phase 1 clinical trial for the treatment of advanced solid tumors; PRT3645, a cyclin-dependent kinase 4/6 inhibitor, which is in Phase 2 clinical trial for the treatment of advanced and metastatic solid tumors; and PRT3879, a SMARCA2 selective protein degrader, which is in Phase 1 clinical trial for the treatment of advanced and metastatic solid tumors with loss of SMARCA4 due to truncating mutation and/or deletion. The company was incorporated in 2016 and is headquartered in Wilmington, Delaware.", "fullTimeEmployees": 122, "companyOfficers": [{"maxAge": 1, "name": "Dr. Krishna  Vaddi D.V.M., Ph.D.", "age": 56, "title": "Founder, CEO & Director", "yearBorn": 1966, "fiscalYear": 2022, "totalPay": {"raw": 805908, "fmt": "805.91k", "longFmt": "805,908"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 3838080, "fmt": "3.84M", "longFmt": "3,838,080"}}, {"maxAge": 1, "name": "Dr. Edna  Huang M.D.", "age": 49, "title": "Pres & Chief Medical Officer", "yearBorn": 1973, "fiscalYear": 2022, "totalPay": {"raw": 563555, "fmt": "563.55k", "longFmt": "563,555"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Peggy A. Scherle Ph.D.", "age": 61, "title": "Chief Scientific Officer", "yearBorn": 1961, "fiscalYear": 2022, "totalPay": {"raw": 868617, "fmt": "868.62k", "longFmt": "868,617"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 436567, "fmt": "436.57k", "longFmt": "436,567"}}, {"maxAge": 1, "name": "Mr. Laurent  Chardonnet M.B.A.", "age": 57, "title": "Chief Financial Officer", "yearBorn": 1965, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Ms. Aimee  Crombie Ph.D.", "title": "Sr. VP and Head of Strategic Planning & Operations", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Madhu  Pudipeddi Ph.D.", "title": "Sr. VP of Technical Operations", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Lindsey  Trickett", "title": "VP of Investor Relations", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Bryant David Lim J.D.", "age": 51, "title": "Chief Legal Officer & Corp. Sec.", "yearBorn": 1971, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Ms. Michele  Porreca M.B.A.", "title": "Chief People Officer", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Andrew P. Combs Ph.D.", "age": 56, "title": "Exec. VP & Head of Chemistry", "yearBorn": 1966, "fiscalYear": 2021, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}], "auditRisk": 2, "boardRisk": 6, "compensationRisk": 9, "shareHolderRightsRisk": 10, "overallRisk": 8, "governanceEpochDate": 1682899200, "compensationAsOfEpochDate": 1672444800, "maxAge": 86400}}], "error": null}}